ArticleMagnetic resonance in medicine2026
On-Scanner Correction of Gradient Nonlinearity Bias for Accurate Assessment of Diffusion Heterogeneity Across Bone Sites in Myelofibrosis Patients.
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo improve accuracy of apparent diffusion coefficient (ADC) measurement across different bone-marrow (BM) sites for myelofibrosis (MF) patients.
methodsVendor-provided ADC gradient nonlinearity correction (GNC) was implemented for 41 MF study subjects on a 3T clinical scanner. The degree of bias correction was assessed on b-maps across the BM regions-of-interest defined for femoral trochanter, posterior ilium and spine vertebrae of all subjects. Bias variability from subject repositioning was evaluated for five subjects with longitudinal scans using Bland-Altman analysis. BM ADC with and without GNC were compared in 22 subjects with MF grade > 0 (iliac fat fraction < 40%). The GNC effect on ADC heterogeneity trends across bone sites was assessed using paired t-test and correlation to MF-grade.
resultsThe observed bias was substantial across BM sites ranging from -10% for edge vertebrae to +8.4% for trochanter across all subjects with a 13.7% intra-subject median range. The effect of irreproducible positioning in longitudinal scans was ±4.2% bias (95% limits-of-agreement) with range of ±8.5% (highest for L1 and L5). By removing bias, GNC improved ADC accuracy and longitudinal reproducibility and emphasized biological heterogeneity for femoral trochanter versus ilium and edge vertebrae (T11-L1, L5, and S1). GNC revealed significant ADC differences between trochanters and edge vertebrae (p = 0.007), while edge vertebrae and ilium ADC became more uniform (p = 0.07), with heterogeneity and values correlated to MF-grade.
conclusionOn-scanner correction of gradient nonlinearity bias in bone marrow ADC reduces technical nonuniformity and variability and allows accurate and reproducible characterization of heterogeneous disease for myelofibrosis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.